The authors identified a proteomic signature based on 3 proteins (DHB12, HMGB3, and COBA1) and developed a model that included the 3 proteins and tumor stage that exhibited >80% predictive accuracy for the development of metastasis and recurrence. This evidence concerns the gene HMGB3 and neoplasm.